Biotechnology This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory.

Best Doctors — Alex Ammar
Wichita Surgical Specialists Education: MD, University of Virginia School of Medicine. Employment History: Wichita Surgical Specialists PA 1982 to present. WHY DID YOU BECOME A DOCTOR? Rewarding to help others and improve their lives. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? Vascular surgery was a new specialty when I was applying for advanced training beyond general surgery. I was attracted to the detail and meticulous requirements of this field. WHAT ADVICE DO YOU HAVE FOR PEOPLE CONSIDERING… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — Richard Steinberger
Wichita Urology Group Education: MD, University of Torino, Italy. Employment History: Medical school and residency/fellowship, have practiced in Wichita since. WHY DID YOU BECOME A DOCTOR? Being a physician allows me to enjoy both science and interact with people in a positive way. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? When l was a medical student I was fascinated by technology and urology is one of the specialities that has always been on the cutting edge. We were among the first to use… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — James Gilbaugh
Wichita Urology Group EDUCATION: MD, Oregon Health Sciences University. EMPLOYMENT HISTORY: Wichita Urology Group. WHY DID YOU BECOME A DOCTOR? It combines the science of medicine with the art of caring for people on a one-on-one basis and helping them solve their medical problems. Often times it is more art than science. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? Urology involves both medical treatments and surgical procedures and you often get to see immediate, tangible results of the care you… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — Douglas Milfeld
Wichita Surgical Specialists Education: MD, Baylor College of Medicine. Employment History: Surgery resident, Baylor college of medicine, 1972-1979; Wichita Surgical Specialists, 1979- present. WHY DID YOU BECOME A DOCTOR? To help folks in a meaningful way. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? Fits into one of my approaches to life: Not always right, but never in doubt. Inspiration from surgery professors. WHAT ADVICE DO YOU HAVE FOR PEOPLE CONSIDERING BECOMING A DOCTOR? Be passionate —… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — Gyan Khicha
Wichita Surgical Specialists Education: MD, Sawai Man Singh Medical College, University of Rajasthan - Jaipur, India. Employment History: Wichita Surgical Specialists PA. WHY DID YOU BECOME A DOCTOR? I loved the work of family doctor who was taking care of our family. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? I was influenced by my professor and enjoyed challenges of cardiac surgery. WHAT ADVICE DO YOU HAVE FOR PEOPLE CONSIDERING BECOMING A DOCTOR? It is hard work but also lots of fun to help… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — Thomas Estep
Wichita Surgical Specialists Education: MD, University of Calgary faculty of medicine. Employment History: Wichita Surgical Specialists. WHY DID YOU BECOME A DOCTOR? Involvement in improving the human experience. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? Desire to pursue life-saving procedures. WHAT ADVICE DO YOU HAVE FOR PEOPLE CONSIDERING BECOMING A DOCTOR? Be honest with your true aims in life. IF YOU COULD CHANGE ONE THING ABOUT YOUR PROFESSION, WHAT WOULD IT BE? Tort reform. WHAT DO YOU… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — Matthew Arneson
Wichita Surgical Specialists Education: MD, University of Washington Medical School, Seattle, Wash. Employment History: Wichita Surgical Specialists 2006-current. WHY DID YOU BECOME A DOCTOR? I was first introduced to the medical community at age 12 when my father was diagnosed with terminal lung cancer. The way physicians can influence patients and their families lives was profound. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? Cardiothoracic surgery is one of a few fields in medicine that requires… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — William Waswick
Kansas Surgical Consultants Education: MD, University of Kansas School of Medicine. Employment History: Kansas Surgical Consultants. WHY DID YOU BECOME A DOCTOR? I’m not certain really. It was a good fit for my personality. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? I enjoyed working with my hands. WHAT ADVICE DO YOU HAVE FOR PEOPLE CONSIDERING BECOMING A DOCTOR? Find your passion and go for it! IF YOU COULD CHANGE ONE THING ABOUT YOUR PROFESSION, WHAT WOULD IT BE? Less time spent on… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — Scott Porter
Kansas Surgical Consultants Education: University of Kansas School of Medicine. Employment History: Kansas Surgical Consultants. WHY DID YOU BECOME A DOCTOR? I realized my fourth year in college that I did not want to spend my life in the laboratory, so I decided to go to medical school. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? I was interested in primary care until I took my surgery rotation. I was spending a lot of time at the hospital and was enjoying every minute of it. WHAT ADVICE DO YOU… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Best Doctors — Richard Guthrie
Mid-America Diabetes Associates Education: MD, University of Missouri School of Medicine. Employment History: Mid-America Diabetes Associates; Family practice; KUMC-Wichita; University of Missouri. WHY DID YOU BECOME A DOCTOR? I always had an interest in science. My father, who was a minister, encouraged me to use that interest to go into medicine to better help humankind. HOW DID YOU CHOOSE YOUR AREA OF PRACTICE? I was awaiting appointment to a church mission and needed income. A fellowship… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 17, 2013 Category: Biotechnology Source Type: research

Evaluation of wavelength selection methods for 2D fluorescence spectra applied to bioprocesses characterization
In biotechnological processes, the productivity and costs depend strongly on the control of the operating conditions. For this reason, sensors that allow the monitoring of variables of interest become quite important. 2D fluorescence spectroscopy is one promising option among those that are being applied for this purpose. In the present work, three methods were evaluated to select the best excitation/emission wavelength pairs of 2D fluorescence spectra to infer product, substrate and cellular concentrations throughout a fermentation using a multiple linear chemometric model: Exhaustive Search (ES), Stepwise Regression and ...
Source: Brazilian Journal of Chemical Engineering - May 16, 2013 Category: Chemistry Source Type: research

New Biotechnology Paradigm: Cell-Free Biosystems for Biomanufacturing
Green Chem., 2013, Accepted ManuscriptDOI: 10.1039/C3GC40625C, PerspectiveJoe Rollin, Ward Tam, Y-H Percival ZhangCost-efficient production of sustainably-derived biochemicals and biofuels is a critical goal of modern biotechnology. The current predominant biotransformation method is mainly based on microbial fermentation, but this system suffers from...The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC - Green Chem. latest articles)
Source: RSC - Green Chem. latest articles - May 16, 2013 Category: Chemistry Authors: Joe Rollin Source Type: research

Locked nucleic acid: tighter is different
Chem. Commun., 2013, Advance ArticleDOI: 10.1039/C3CC40340H, ViewpointJonathan K. WattsThis viewpoint briefly reviews the impact of Locked Nucleic Acid (LNA) oligonucleotides, first described in a ChemComm paper in 1998. A number of unique applications in oligonucleotide biotechnology have been made possible by the high binding affinity and specificity of LNA, and these provide the main focus of the viewpoint.To cite this article before page numbers are assigned, use the DOI form of citation above.The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC - Chem. Commun. latest articles)
Source: RSC - Chem. Commun. latest articles - May 16, 2013 Category: Chemistry Authors: Jonathan K. Watts Source Type: research

Engineered Biomaterial Could Eliminate The Body's Negative Reaction To Medical Implants
It's a familiar scenario - a patient receives a medical implant and days later, the body attacks the artificial valve or device, causing complications to an already compromised system. Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body's natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated in mice a way to prevent this sort of response. Their findings were published online this week in the journal Nature Biotechnology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 16, 2013 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news

Design, synthesis, and assessment of a de novo affinity adsorbent for the purification of recombinant human erythropoietin
This study demonstrates the potential of Ugi scaffolds to generate affinity adsorbents for the future development of cost‐effective purification protocols for rHuEPO. (Source: Biotechnology and Bioengineering)
Source: Biotechnology and Bioengineering - May 16, 2013 Category: Biomedical Science Authors: Graziella El Khoury, Yian Wang, Di Wang, Shaleem I. Jacob, Christopher R. Lowe Tags: Communication to the Editor Source Type: research

High‐throughput screening for the development of a monoclonal antibody affinity precipitation step using ELP‐z stimuli responsive biopolymers
This study provides a detailed investigation into the performance of a stimuli responsive ELP‐Z based process for monoclonal antibody (mAb) affinity precipitation. A multidimensional high‐throughput screening (HTS) protocol was developed and employed to investigate the effects of a variety of operating conditions on mAb yield and aggregation during the process. Precipitation efficiency of ELP‐Z in the absence of mAb was first determined as a function of temperature and sodium sulfate concentration and conditions producing high yields were identified. HTS was then employed to determine appropriate conditions for the i...
Source: Biotechnology and Bioengineering - May 16, 2013 Category: Biomedical Science Authors: Rahul D. Sheth, Bhawna Madan, Wilfred Chen, Steven M. Cramer Tags: Article Source Type: research

Patient-Specific Human Embryonic Stem Cells Created by Cloning
From Nature magazine [More] (Source: Scientific American Topic - Biotechnology)
Source: Scientific American Topic - Biotechnology - May 15, 2013 Category: Biotechnology Tags: Health,Technology,Society & Policy,Medical Technology,Biotechnology,Biotechnology,Ethics,Health,More Science Source Type: news

Justices Support Monsanto In Seed Patent Dispute
Biotechnology: Supreme Court rules genetically modified crops entitled to same protections as other inventions (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - May 15, 2013 Category: Chemistry Authors: Glenn Hess Source Type: research

M-Files QMS Deployed by MolecularMD for Laboratory Documentation and...
Provider of Diagnostics Products and Services to Pharmaceutical and Biotech Companies Implements M-Files QMS(PRWeb May 14, 2013)Read the full story at http://www.prweb.com/releases/2013/5/prweb10728079.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 15, 2013 Category: Pharmaceuticals Source Type: news

Accelrys Externalized Collaboration Suite Moves Research Networks To The Cloud
Bio-IT World, Boston – Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of the Accelrys Externalized Collaboration Suite, a software solution designed specifically to address the needs of life sciences organizations engaged in externalized network research. The suite is the only offering currently available that addresses the full range of externalization needs from technology transfer through networked collaboration to scientific informatics across all research data including experiments, chemical structures, assays and other test resu...
Source: Pharmaceutical Online News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Therapure Biopharma Receives BIOTECanada Gold Leaf Award
Therapure Biopharma is pleased to announce today that it has been awarded the Gold Leaf Award for Emerging Company of the Year by BIOTECanada in the Health Biotech Category for 2012. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 15, 2013 Category: Pharmaceuticals Source Type: news

Exclusive Q&A With a Woman Pioneer in Biotech
Innovation thrives when different people come together. Diversity stimulates imagination and new ideas. However, 35 years ago, there were very few women in life sciences and venture capital. Nola Masterson was a pioneer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2013 Category: Pharmaceuticals Authors: Victor W. Hwang Source Type: news

Development of rotavirus a significant victory: US
US today congratulated India for developing an indigenous rotavirus vaccine for prevention of diarrhoea, terming it a significant victory. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Take steps to stop use of adulterated drugs in India: Rajinder Sachar
Former chief justice of Delhi High Court Rajinder Sachar has demanded that Indian authorities take steps to stop their use in the country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Patheon to Feature its Complex Formulation Technologies Expertise
Patheon personnel will be available to meet at the CPhI/ICSE Japan conference in Tokyo from April 24-26, 2013 to discuss how Patheon can actively support pharmaceutical and biotech companies achieve their key development and manufacturing goals (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - May 15, 2013 Category: Pharmaceuticals Source Type: news

Phase III Clinical Trial Results For Rotavirus Vaccine Developed In India
The Government of India's Department of Biotechnology (DBT) and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial, presented at the International Symposium on Rotavirus Vaccines for India -The Evidence and the Promise, showed ROTAVAC® to have an excellent safety and efficacy profile. The clinical study demonstrates for the first time that the India-developed rotavirus vaccine ROTAVAC® is efficacious in preventing severe rotavirus diarrhoea in low-resource settings in India... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 15, 2013 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news

Synthetic analog computation in living cells
Nature advance online publication 15 May 2013. doi:10.1038/nature12148 Authors: Ramiz Daniel, Jacob R. Rubens, Rahul Sarpeshkar & Timothy K. Lu A central goal of synthetic biology is to achieve multi-signal integration and processing in living cells for diagnostic, therapeutic and biotechnology applications. Digital logic has been used to build small-scale circuits, but other frameworks may be needed for efficient computation in the resource-limited environments of cells. Here we demonstrate that synthetic analog gene circuits can be engineered to execute sophisticated computational functions in living cells using jus...
Source: Nature AOP - May 15, 2013 Category: Research Authors: Ramiz DanielJacob R. RubensRahul SarpeshkarTimothy K. Lu Tags: Letter Source Type: research

Ranbaxy may take a $1-billion hit in US
The damage to India’s largest drug major, Ranbaxy , translates well beyond the $500 million -which was confirmed as total penalty on May 13. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

Australia Welcomes Custom Mammalian-Based Biopharmaceutical Manufacturing
DSM Pharmaceutical Products announced at Bio International 2013 that its’ new cGMP custom biopharmaceutical manufacturing ‘biologics plant of the future’ was set to open in June 2013 in Brisbane, Australia. The facility will be adjacent to the Translational Research Institute of Queensland, Australia’s comprehensive medical research and biopharmaceutical facility located on the Princess Alexandra Hospital campus. The state-of-the-art commercial and development facility was built with the cooperation of the Queensland and Commonwealth Governments of Australia. Australia currently has a vibrant biote...
Source: Pharmaceutical Online News - May 14, 2013 Category: Pharmaceuticals Source Type: news

Scientists unveils first Made in India rotavirus vaccine
Scientists today unveiled the first completely indigenous and affordable vaccine to prevent severe rotavirus diarrhoea, which kills more than one lakh children under the age of five in India very year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

Piramal gets USDFA nod for anti-diabetic molecule
Piramal Enterprises today said it has received approval from the USFDA for its investigational new drug, P11187, that aims to target diabetes. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

MSD India to invest $10 mn to cut maternal mortality
MSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar Pradesh. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2013 Category: Pharmaceuticals Source Type: news

Engineered biomaterial could improve success of medical implants
(University of Washington) Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body's natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated in mice a way to prevent this sort of response. Their findings were published online this week in the journal Nature Biotechnology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2013 Category: Global & Universal Source Type: news

Rotavirus vaccine developed in India demonstrates strong efficacy
(PATH) The Government of India's Department of Biotechnology and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial, presented today at the International Symposium on Rotavirus Vaccines for India -- The Evidence and the Promise, showed ROTAVAC® to have an excellent safety and efficacy profile. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2013 Category: Global & Universal Source Type: news

The Supreme Court Takes On the Patent Eligibility of Human Genes: AMP v. Myriad
Biotechnology Law Report , Vol. 0, No. 0. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - May 13, 2013 Category: Medical Law Tags: article Source Type: research

Lobby fears norms violation in Cipla's biosimilar drug
A lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 13, 2013 Category: Pharmaceuticals Source Type: news

Goldman Sachs to invest Rs 110 cr in BPL Med
Medical device company BPL Medical Technologies has secured an equity commitment of Rs 110 crore ($ 20 million) from Goldman Sachs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 13, 2013 Category: Pharmaceuticals Source Type: news

FDA accepts Biogen’s application for hemophilia A candidate
The U.S. Food and Drug Administration has accepted the second of the two applications for a biologic drug candidate to treat hemophilia that Biogen Idec. (Nasdaq:BIIB) plans to submit this year. On Monday the Weston, Mass.-based biotech announced that the FDA has accepted the Biologics License Application (BLA) for Eloctate for the treatment of hemophilia A. Eloctate is a recombinant factor VIII Fc fusion protein which delays the destruction of an essential blood-clotting protein, allowing for longer… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - May 13, 2013 Category: Hospital Management Authors: Don Seiffert Source Type: research

Domestic pharma growth rebounds for the month of April
There was an improvement of growth in case of the anti-infectives segment, being the largest category in the Indian pharmaceutical market constituting nearly 18% of the industry revenues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 13, 2013 Category: Pharmaceuticals Source Type: news